Safety and Efficacy of Low Doses of V24343 in Obese Subjects

NCT00734201 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: V24343

Sponsor

Vernalis (R&D) Ltd